Importer of Controlled Substances Registration, 5478 [2019-02870]

Download as PDF 5478 Federal Register / Vol. 84, No. 35 / Thursday, February 21, 2019 / Notices Controlled substance Drug code Cocaine .................... Codeine .................... Dihydrocodeine ......... Oxycodone ............... Hydromorphone ........ Diphenoxylate ........... Ecgonine ................... Hydrocodone ............ Meperidine ................ Methadone ................ Methadone intermediate. Morphine ................... Thebaine ................... Opium tincture .......... Oxymorphone ........... Noroxymorphone ...... Alfentanil ................... Remifentanil .............. Sufentanil .................. Tapentadol ................ Fentanyl .................... Schedule 9041 9050 9120 9143 9150 9170 9180 9193 9230 9250 9254 II II II II II II II II II II II 9300 9333 9630 9652 9668 9737 9739 9740 9780 9801 II II II II II II II II II II below. No comments or objections were submitted for this notice. Company Sigma Aldrich Research. FR docket Published 83 FR 54613 October 30, 2018. The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of this registrant to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed company. In reference to drug codes 7360 (Marijuana), and 7370 (THC), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Dated: January 29, 2019. John J. Martin, Assistant Administrator. Dated: February 11, 2019. John J. Martin, Assistant Administrator. Myoderm ...... 83 FR 66751 December 27, 2018. The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrant to import the applicable basic class of schedule II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule II controlled substances to the above listed company. Dated: February 11, 2019. John J. Martin, Assistant Administrator. BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Enforcement Administration [Docket No. DEA–392] [Docket No. DEA–392] Importer of Controlled Substances Registration Bulk Manufacturer of Controlled Substances Registration ACTION: Notice of registration. The registrant listed below has applied for and has been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various classes of schedule I and II controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as a bulk manufacturer of various basic classes of controlled substances. Information on the previous published notice are listed in the table Company Jkt 247001 Importer of Controlled Substances Registration ACTION: Notice of registration. The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I or schedule II controlled substances. The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices. SUPPLEMENTARY INFORMATION: FR docket Janssen Pharmaceuticals, Inc .......................................... Lipomed ............................................................................ Akorn, Inc .......................................................................... Cambridge Isotope Laboratories ...................................... GE Healthcare .................................................................. Fisher Clinical Services, Inc ............................................. 17:08 Feb 20, 2019 [Docket No. DEA–392] SUMMARY: The registrant listed below has applied for and has been granted registration by the Drug Enforcement Administration (DEA) as an importer of schedule II controlled substances. SUPPLEMENTARY INFORMATION: The company listed below applied to be registered as an importer of a basic class of controlled substance. Information on the previously published notice is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for this notice. SUMMARY: Notice of registration. SUMMARY: amozie on DSK3GDR082PROD with NOTICES1 Published BILLING CODE 4410–09–P BILLING CODE 4410–09–P VerDate Sep<11>2014 FR docket [FR Doc. 2019–02870 Filed 2–20–19; 8:45 am] [FR Doc. 2019–02869 Filed 2–20–19; 8:45 am] [FR Doc. 2019–02882 Filed 2–20–19; 8:45 am] ACTION: Company PO 00000 83 83 83 83 83 83 FR FR FR FR FR FR Frm 00075 58598 58601 60896 60897 60899 60900 Fmt 4703 Published ................................................................... ................................................................... ................................................................... ................................................................... ................................................................... ................................................................... Sfmt 4703 E:\FR\FM\21FEN1.SGM 21FEN1 November November November November November November 20, 20, 27, 27, 27, 27, 2018. 2018. 2018. 2018. 2018. 2018.

Agencies

[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Page 5478]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02870]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrant listed below has applied for and has been 
granted registration by the Drug Enforcement Administration (DEA) as an 
importer of schedule II controlled substances.

SUPPLEMENTARY INFORMATION: The company listed below applied to be 
registered as an importer of a basic class of controlled substance. 
Information on the previously published notice is listed in the table 
below. No comments or objections were submitted and no requests for 
hearing were submitted for this notice.

------------------------------------------------------------------------
            Company                FR docket           Published
------------------------------------------------------------------------
Myoderm........................   83 FR 66751  December 27, 2018.
------------------------------------------------------------------------

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrant to 
import the applicable basic class of schedule II controlled substances 
is consistent with the public interest and with United States 
obligations under international treaties, conventions, or protocols in 
effect on May 1, 1971. The DEA investigated the company's maintenance 
of effective controls against diversion by inspecting and testing the 
company's physical security systems, verifying the company's compliance 
with state and local laws, and reviewing the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule II controlled substances to the above listed 
company.

    Dated: February 11, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02870 Filed 2-20-19; 8:45 am]
 BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.